A new step for DECIPHER LabCom!
A few months ago, we announced the launch of DECIPHER, a joint academic–industrial laboratory between TAGC /INSERM / Aix-Marseille University and Advanced BioDesign, supported through the ANR, the French National Research Agency LabCom framework and with the additional support of a*midex aix marseille universite.
✨ Today, I am pleased to invite you to visit the new DECIPHER website and discover how this collaborative platform is taking shape:
https://lnkd.in/dH9txCpq
The platform already highlights several scientific advances emerging from this shared effort, with a particular focus on identifying vulnerabilities linked to adaptive resistance mechanisms in cancer.
✨ This is also a great opportunity to warmly welcome Dr. Iris Manosalva fully on board DECIPHER. Her expertise in CRISPR-based screening, epigenetics, gene regulation and cancer models will be highly valuable for the next steps of the project.
Many thanks to Salvatore Spicuglia, DECIPHER coordinator and scientific lead at TAGC, the TAGC team, a*midex aix marseille universite, Advanced BioDesign, and all our academic and clinical collaborators for making this collaborative translational research initiative possible.
Looking forward to the next discoveries emerging from DECIPHER.
#DECIPHER #LabCom #ANR #AMidex #CancerResearch #TranslationalOncology #DrugResistance #CRISPR #Epigenetics #ALDH1 #DIMATE #AdvancedBioDesign #TAGC